Nikkei Inc. and AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) jointly held the Fourth Meeting of Working Group 2 Under the Sub-committee on AMR of the Nikkei FT Communicable Diseases Conference  Asia Africa Medical Innovation Consortium (AMIC). 

Working groups (WG) were established under the Sub-committee on AMR of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC) in order to discuss the state of the antimicrobial market.

At this fourth meeting of WG2, participants discussed the collection of data needed to further policy discussions on AMR.

In light of the situation with novel coronavirus, this meeting was carried out primarily online. On-site participants were encouraged to keep a safe physical distance from each other.

Please access our policy recommendations “Strengthening AMR Countermeasures to Respond to Health Crises Recommendations to the Japanese Government on Establishing a Pull Incentive System for the Antimicrobial Market: Creating an Ecosystem for Sustainable Antimicrobial Development to Protect the Lives of the Public Executive Summary”  here

■Overview

Date and time: Wednesday, July 30, 2021
Organizer: AMR Alliance Japan (Secretariat: HGPI), Nikkei Inc.

■Discussion

WG2 Members (alphabetical order by last name):
Yusuke Ariyoshi (Director, Healthcare Policy, Government Affairs Dept., Shionogi & Co., Ltd.)
Yoshiaki Gu (Professor, Department of Integrated Clinical Infectious Diseases, Graduate School of Medicine and Dental Sciencs, Tokyo Medical and Dental University)
Keiji Hirai (Advisor, Kyorin Pharmaceutical Co., Ltd.) *Observer
Kazumasa Oguro (Professor, Faculty of Economics, Hosei University)
Takuko Sawada (Director of the Board, Executive Vice President, Shionogi & Co., Ltd.)
Motoyuki Sugai (Director, Antimicrobial Resistance Research Center, National Institute of Infectious Diseases)
Yoshisaburo Takahashi (General Manager, Vaccine/Infections Dept., Meiji Seika Pharma Co., Ltd.)
Yasunori Tawaragi (Sustainability Promotion Department, Daiichi Sankyo Co., Ltd./Director, AMR Incentives and Advocacy TF, Japan Pharmaceutical Manufacturers Association)
Akira Yuasa (Senior Manager, HTA/HEOR, Corporate Affairs, Health & Value, Pfizer Japan Inc.)

Moderator:
Yui Kohno (AMR Alliance Japan Secretariat/Associate, HGPI)

Secretariat (alphabetical order by last name):
Yuiko Kondo (AMR Alliance Japan Secretariat/Senior Associate, HGPI)
Matt McEnany (AMR Alliance Japan Secretariat/Senior Manager, HGPI)
Tomohito Shibata (AMR Alliance Japan Secretariat/Senior Associate, HGPI)
Chiaki Toma (The Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) Project, Nikkei Inc.)
Mio Wakasa (The Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) Project, Nikkei Inc.)

■Related events held as part of the “The Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)” project in and after FY2019 (chronological order)

January 22, 2020 The First Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
March 11, 2020 The First Meeting of Working Group 1 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
March 19, 2020 The Second Meeting of Working Group 1 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
March 24, 2020 The First Meeting of Working Group 2 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
April 27, 2020 The Second Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
July 17, 2020 The Third Meeting of Working Group 1 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
August 18, 2020 The Second Meeting of Working Group 2 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
August 27, 2020 The Fourth Meeting of Working Group 1 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
September 14, 2020 The First Meeting of Working Group 3 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
September 23, 2020 The Third Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
October 7, 2020 The Fifth Meeting of Working Group 1 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC)
October 8, 2020 The Third Meeting of Working Group 2 Under the Sub-committee on AMR of the Nikkei Asia Africa Conference on Communicable Diseases – Asia Africa Medical Innovation Consortium (AMIC) 
November 7, 2020 The 7th NIKKEI FT Communicable Diseases Conference – The AMR Consortium of the Asia Africa Medical Innovation Consortium (AMIC)
December 14, 2020 The Fourth Meeting of the AMR Consortium of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC)
March 12, 2021 The Fifth Meeting of the AMR Consortium of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC)
May 28, 2021 The Second Meeting of Working Group 3 Under the Sub-committee on AMR of the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC)